December 11, 2009
1 min read
Save

Ptosis can develop after sub-Tenon triamcinolone acetonide injection but can be resolved

Can J Ophthalmol. 2009;44(6):668-672.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

While 5% of eyes that received sub-Tenon injection of triamcinolone acetonide developed secondary ptosis, reconstructive surgery was successful, and satisfactory results were achieved after injection in all cases, a study found.

"A sub-Tenon [triamcinolone acetonide] injection can occasionally cause ptosis by inducing a disinsertion of the levator aponeurosis. However, surgical reconstruction can lead to successful resolution of the ptosis," the authors said.

The retrospective cross-sectional study examined 163 eyes, for a total of 147 cases that had 286 sub-Tenon injections of 10-mg or 20-mg triamcinolone acetonide. The study determined incidence of secondary ptosis after injection.

Secondary ptosis developed in eight eyes (5%) in the study; six eyes were treated with reconstructive surgery. Two eyes required additional sub-Tenon triamcinolone acetonide injections and did not experience worsening ptosis.

According to the study, improvement of the margin reflex distance was –1.3 mm to 2.3 mm (P = .027) after injections..